Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Hair changes can indicate systemic diseases or medication effects.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Tofacitinib helped regrow hair in most patients with severe hair loss.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Skin symptoms can indicate endocrine disorders and have various treatments.

MPA increases cancer spread by boosting Eph A2 activity.

Some chemicals can permanently or temporarily remove color from skin and hair, which can be distressing and is not well-regulated in cosmetics.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

A new mutation in the K6b gene caused a girl's late-appearing nail condition.

Sex hormones affect brain injury differently in males and females.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Wnt5a slows down hair growth by blocking a specific pathway during hair regeneration.

Method accurately measures finasteride in tablets using finasteride-BSA interaction.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Low dose methotrexate does not increase hair fall and may reduce it.

Ephrin-A3 helps increase and speed up hair growth in baby mice.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

A rare EGFR mutation in newborns leads to severe health issues and early death.

Immune cells and cytokines significantly affect pathological scar development.

Finasteride can cause long-term side effects like sexual dysfunction and depression.